GratXray AG

GratXray is an innovative medical technology company dedicated to transforming diagnostic imaging. As a spin-off from the Paul Scherrer Institute (PSI) and ETH Zurich, we combine world-class research with practical innovation to address real clinical needs.

Our first product, senoa, seeks to revolutionize breast cancer diagnosis with pain-free, high-precision 3D imaging. By eliminating the compression required in traditional mammography and prioritizing patient comfort, we’re making life-saving breast cancer imaging more accessible, especially for women who have avoided it due to discomfort or fear.

Beyond senoa, we are committed to continuous innovation across medical imaging. We leverage cutting-edge technologies developed with our research partners to enhance our devices and explore new clinical applications. Our vision is to set new standards in diagnostic imaging, one breakthrough at a time.